Create PFAS Methods in Minutes with Restek’s Free Pro EZLC Chromatogram Modeler
PFAS methods can now be developed quickly, virtually, and at a fraction of the cost using the Pro EZLC chromatogram modeler. The new 58-compound PFAS library covers most major methods, and this easy-to-use yet powerful tool allows analysts to simulate method conditions and model changes before ever setting foot in the lab. Simply input your compound list to instantly generate an instrument-ready set of conditions. You can further refine the initial model to meet specific method requirements by changing the column phase and dimensions, mobile phase, and other optimization parameters. No experimental input is needed because EZLC models are based on robust algorithms and experimental data already generated by Restek’s scientists. Speed up PFAS method development significantly with highly accurate liquid chromatography simulations from Restek’s Pro EZLC chromatogram modeler. Drugs of abuse and nitrosamine libraries are alsCreate PFAS Methods in Minutes with Restek’s Free Pro EZLC Chromatogram Modelero available and other compound classes are coming soon.
Take a video tour at www.restek.com/proezlc
Restek Corporation
1-814-353-1300, ext. 3
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.
